Idaho settles GlaxoSmithKline case for $2.6 million
BOISE, Idaho — Drugmaker GlaxoSmithKline has agreed to pay the state of Idaho $2.6 million to settle allegations that the company sold products at false or inflated prices, CNBC reported.
The agreement marks the state''s 14th settlement over price fixing matters with drug companies since 2005.
An investigation revealed the company inflated average wholesale prices of drugs eligible for Medicaid reimbursement by as much as 27 percent.
The inflated price results in overpayments to pharmacies that provide the drugs to Idaho Medicaid clients.